Anti-NMDA receptor antibody encephalitis and neuroendocrine pancreatic tumor: Causal link?
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
Vadim
V
Afanasiev
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
Marie-Laure
ML
Brechemier
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
William
W
Boisseau
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
Romain
R
Ducoudray
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
Marie-Eve
ME
Mayeur
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
David
D
Meyronet
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
Anne
A
Peskine
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France.
Virginie
V
Desestret
From the Neurology Department (V.A., M.-L.B.), Saint-Antoine Hospital, Université Pierre et Marie Curie, Paris; Neuro-Oncology Department, Mazarin (W.B., D.P.), General, Visceral and Endocrine Surgery Department (R.D.), Physical Medicine and Rehabilitation Department (A.P.), Groupe Hospitalier Pitié-Salpétrière Université Pierre et Marie Curie, Paris; INSERM U1028 (M.-E.M., D.M., V.D.), CNRS UM5292, Neuro-oncology and Neuro-inflammation Team, Université Claude Bernard Lyon 1; and Pathology and Neuropathology Est Center (D.M.), Hospices Civils de Lyon, France. dimitri.psimaras@aphp.fr.
Dimitri
D
Psimaras
D060426:Anti-N-Methyl-D-Aspartate Receptor Encephalitis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000601:surgery